Homeostasis model assessment (HOMA) (23) was conducted to assess/H9252-cell function at baseline and at days 14 and 28. The HOMA scores (24) were cal-culated as follows: HOMA /H9252-cell index /H1100520/H11003fasting insulin ( /H9262U/ml) fasting glucose (mmol/l) /H110023.5 Safety was evaluated using spontaneous adverse event reporting and monitoringof clinical laboratory measures and vitalsigns. Nausea was assessed as part of theroutine adverse eventâ€“gathering process. Statistical analysis